NEOGENOMICS INC 4
4 · NEOGENOMICS INC · Filed Mar 22, 2017
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2017-03-20$7.90/sh−33,450$264,255→ 15,953 total - Sale
Common Stock
2017-03-13$8.00/sh−16,550$132,400→ 49,403 total
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (20,000 underlying) - 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $3.76From: 2014-04-16Exp: 2018-04-16→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]This line is included for purposes of amending the filing on 3/17/2017 which inadvertently showed the transaction as securities acquired rather than securities disposed of.
- [F2]On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant dates.
- [F3]On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F4]On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F5]On April 20, 2016, Mr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.